CGN.DE

Cigna Corporation [CGN.DE] Stock Forecast

Q: What is Cigna Corporation stock symbol ?

Cigna Corporation is a US stock, located in Bloomfield of Ct and trading under the symbol CGN.DE

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

CGN.DE Stock Summary

Earnings are expected to rise 4.57% next year

CGN.DE's dividend payments are well covered by cash flows with cash payout ratio of 25.71%.

Profit margins (0.03%) are lower than the previous year (0.04%)

CGN.DE's dividend payments have fallen since the beginning of the year

CGN.DE has less than 1 year of cash runway

In the News

CGN.DE Financial details

Company Rating

Strong Buy

Market Cap

77.13B

Income

5.3B

Revenue

189.85B

Book val./share

155.38

Cash/share

32.45

Dividend

4.66

Dividend %

1.64%

Employees

71.3K

Optionable

Shortable

Yes

Earnings

02 Feb 2024

P/E

15.72

Forward P/E

9.61

PEG

12.54

P/S

0.4

P/B

1.83

P/C

8.12

P/FCF

6.92

Quick Ratio

3.13

Current Ratio

3.13

Debt / Equity

0.68

LT Debt / Equity

0.61

EPS (TTM)

17.86

EPS next Y

27.43

EPS next Q

EPS this Y

24.32%

EPS next Y

53.57%

EPS next 5Y

53.57%

EPS last 5Y

13.04%

Revenue last 5Y

30.04%

Revenue Q/Q

0.88%

EPS Q/Q

-3.43%

SMA20

-7.89%

SMA50

SMA100

8.01%

Inst Own

Inst Trans

ROA

ROE

12%

ROC

-0.45%

Gross Margin

100%

Oper. Margin

-33%

Profit Margin

Payout

27%

Shs Outstand

292.62M

Shs Float

291.49M

Target Price

52W Range

221.0-319.65

52W High

-17.37%

52W Low

+19.28%

RSI

37.95

Rel Volume

0.06

Avg Volume

Volume

Perf Week

-3.73%

Perf Month

-2.55%

Perf Quarter

Perf Half Y

6.38%

Beta

0.563

Volatility

4%, 12.44%

Prev Close

-0.42%

Price

263.6

Change

-0.42%

CGN.DE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	196.91	408.98	439.96	515.66	534.5
Net income per share	10.69	13.58	23.17	15.87	19.73
Operating cash flow per share	15.28	25.23	28.36	21.28	25.61
Free cash flow per share	13.14	22.44	25.36	17.86	21.78
Cash per share	23.92	14.78	31.54	17.76	20.21
Book value per share	166.34	120.61	137.87	139.4	132.77
Tangible book value per share	-172.05	-95.19	-80.66	-96.84	-98.69
Share holders equity per share	166.34	120.61	137.87	139.4	132.77
Interest debt per share	174.24	103.98	94.13	103.2	95.64
Market cap	90.62B	135.24B	144.17B	122.92B	111.12B
Enterprise value	129.24B	168.03B	166.91B	151.51B	136.28B
P/E ratio	34.36	26.5	17.05	22.91	16.66
Price to sales ratio	1.87	0.88	0.9	0.71	0.62
POCF ratio	24.04	14.26	13.93	17.09	12.84
PFCF ratio	27.95	16.03	15.58	20.36	15.1
P/B Ratio	2.21	2.98	2.87	2.61	2.48
PTB ratio	2.21	2.98	2.87	2.61	2.48
EV to sales	2.66	1.09	1.04	0.87	0.75
Enterprise value over EBITDA	27.12	-1.81	-1.77	-1.36	20.44
EV to operating cash flow	34.28	17.72	16.13	21.07	15.74
EV to free cash flow	39.86	19.92	18.03	25.1	18.51
Earnings yield	0.03	0.04	0.06	0.04	0.06
Free cash flow yield	0.04	0.06	0.06	0.05	0.07
Debt to equity	1.04	0.83	0.65	0.71	0.69
Debt to assets	0.28	0.24	0.21	0.22	0.22
Net debt to EBITDA	8.11	-0.35	-0.24	-0.26	3.77
Current ratio	3.62	1.01	1.3	2.84	2.67
Interest coverage	8.17	-57.4	-67.41	-94.93	3.04
Income quality	1.42	1.85	1.22	1.33	1.28
Dividend Yield	0.27	0.01	0.03	0.01	0.01
Payout ratio	9.23	0.13	0.58	0.25	0.21
Sales general and administrative to revenue	0.25	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.54	0.52	0.51	0.52	0.54
Capex to operating cash flow	-0.14	-0.11	-0.11	-0.16	-0.15
Capex to revenue	-0.01	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-0.76	-0.29	-0.39	-0.39	-0.44
Stock based compensation to revenue	0	0	-0.03	0	0
Graham number	200.03	191.95	268.12	223.14	242.78
ROIC	0.04	-0.91	-0.91	-1.13	0.04
Return on tangible assets	0.04	0.07	0.11	0.07	0.1
Graham Net	-382.19	-247.33	-220.58	-256.34	-223.93
Working capital	47.13B	314M	6.71B	16.9B	18.02B
Tangible asset value	-42.44B	-35.79B	-29.44B	-32.73B	-33.35B
Net current asset value	-47B	-89.02B	-76.16B	-81.61B	-70.19B
Invested capital	1.04	0.83	0.65	0.71	0.69
Average receivables	12.7B	15.9B	16.6B	18.74B	21.03B
Average payables	12.52B	15.31B	17.18B	12.74B	7.22B
Average inventory	0	0	0	0	0
Days sales outstanding	120.09	37.55	39.53	42.09	44.37
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	3.04	9.72	9.23	8.67	8.23
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0.06	0.11	0.17	0.11	0.15
Capex per share	-2.14	-2.79	-3	-3.41	-3.83

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric	2022-09-30	2022-12-31	2023-03-31	2023-06-30	2023-09-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	148.75	149.77	157.11	165.06	166.77
Net income per share	9.07	3.83	4.28	4.96	4.79
Operating cash flow per share	10.8	6.87	17	8.46	9.61
Free cash flow per share	9.69	5.74	15.62	7.11	8.24
Cash per share	25.87	22.36	29.92	35.51	32.45
Book value per share	148.23	146.92	150.49	154.31	155.38
Tangible book value per share	-110.44	-109.2	-112.67	-108.65	-106.67
Share holders equity per share	148.23	146.92	150.49	154.31	155.38
Interest debt per share	104.93	102.87	111.26	112.38	107.14
Market cap	95.92B	100.41B	81.71B	82.21B	83.91B
Enterprise value	120.42B	125.58B	106.32B	105.36B	106.56B
P/E ratio	8.7	21.47	16.12	14.08	14.9
Price to sales ratio	2.12	2.2	1.76	1.69	1.71
POCF ratio	29.22	47.84	16.25	32.99	29.69
PFCF ratio	32.57	57.25	17.69	39.24	34.63
P/B Ratio	2.13	2.24	1.84	1.81	1.84
PTB ratio	2.13	2.24	1.84	1.81	1.84
EV to sales	2.66	2.75	2.29	2.17	2.17
Enterprise value over EBITDA	26.76	107.43	39.83	-3.36	-3.33
EV to operating cash flow	36.68	59.83	21.15	42.28	37.71
EV to free cash flow	40.89	71.6	23.01	50.29	43.98
Earnings yield	0.03	0.01	0.02	0.02	0.02
Free cash flow yield	0.03	0.02	0.06	0.03	0.03
Debt to equity	0.7	0.69	0.73	0.72	0.68
Debt to assets	0.22	0.22	0.22	0.22	0.21
Net debt to EBITDA	5.44	21.53	9.22	-0.74	-0.71
Current ratio	1.11	2.67	2.95	2.67	3.13
Interest coverage	12.41	1.34	5.36	-88.51	-89.68
Income quality	1.18	1.75	3.85	1.65	1.95
Dividend Yield	0	0	0	0	0
Payout ratio	0.12	0.29	0.29	0.25	0.26
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.55	0.54	0.53	0.52	0.52
Capex to operating cash flow	-0.1	-0.16	-0.08	-0.16	-0.14
Capex to revenue	-0.01	-0.01	-0.01	-0.01	-0.01
Capex to depreciation	-0.47	-0.47	-0.54	-0.53	-0.53
Stock based compensation to revenue	0	0	0	0	0
Graham number	173.96	112.49	120.45	131.19	129.38
ROIC	0.04	0.01	0.02	-0.33	-0.34
Return on tangible assets	0.04	0.02	0.02	0.02	0.02
Graham Net	-245.64	-247.8	-261.37	-259.63	-259.59
Working capital	2.93B	18.02B	21.06B	21.24B	22.83B
Tangible asset value	-33.56B	-33.35B	-33.32B	-32B	-31.37B
Net current asset value	-69.11B	-70.19B	-71.54B	-70.6B	-70.33B
Invested capital	0.7	0.69	0.73	0.72	0.68
Average receivables	22.65B	22.03B	22.48B	23.23B	23.74B
Average payables	23.56B	15.66B	7.57B	7.72B	7.87B
Average inventory	0	0	0	0	0
Days sales outstanding	44.01	43.21	44.54	43.46	44.05
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	2.05	2.08	2.02	2.07	2.04
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0.06	0.03	0.03	0.03	0.03
Capex per share	-1.11	-1.13	-1.38	-1.35	-1.37

CGN.DE Dividend History

CGN.DE Frequently Asked Questions

What is Cigna Corporation stock symbol ?

Cigna Corporation is a US stock , located in Bloomfield of Ct and trading under the symbol CGN.DE

What is Cigna Corporation stock quote today ?

Cigna Corporation stock price is $263.6 today.

Is Cigna Corporation stock public?

Yes, Cigna Corporation is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Same Price Range

Similar Market Cap

Company Profile

Volume Average 16
Market Capitalization 77.13B
Employee 71.3K
CEO Mr. David Michael Cordani
Headquarters Bloomfield,CT,US
IPO Date 2022-11-11
Website https://www.cigna.com

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.